期刊文献+

获得性血管性血友病三例报告并文献复习 被引量:3

Acquired von Willebrand syndrome in three patients and literature review
原文传递
导出
摘要 目的加深对获得性血管性血友病(AVWS)的认识。方法对3例AVWS患者的临床资料进行分析,并复习相关文献。结果①例1,男,70岁,诊断:华氏巨球蛋白血症、AVWS。表现为自发鼻腔、皮肤出血,血管性血友病因子抗原(VWF:Ag)16%。予输注冷沉淀、VDT方案(硼替佐米+沙利度胺+地塞米松)化疗2个疗程,获部分缓解,随访半年无活动性出血。②例2,女,48岁,诊断:意义未明的单克隆丙种球蛋白m症、AVWS。表现为反复齿龈出血,VwF:Ag7%,给予观察随诊。③例3,男,50岁,诊断:意义未明的单克隆丙种球蛋白血症、AVWS。表现为轻微外伤后肌肉血肿,VWF:Ag12%,给予血浆、冷沉淀、大剂量静脉丙种球蛋白输注及利妥昔单抗治疗,随访半年中仍有反复出血。结论AVWS临床表现具有异质性;对原因不明的出血患者应进行血浆VWF:Ag检测;成年AVWS患者应注意寻找原发病;治疗包括控制出血、原发病的治疗和预防出血;预后与原发病有关。 Objective To deepen the understanding of acquired von Willebrand syndrome (AVWS). Methods The clinical data of 3 patients were analyzed and related literature were reviewed. Results ① Case 1, a 70-year-old male, diagnosed as Waldenstrom macroglobulinemia and AVWS, was presented with spontaneous epitaxis and bruising. The VWF: Ag level was 16%. Treatment was initiated with VWF concentrates. Two cycles of chemotherapy with Bortezomib, thalidomide and Dexamethasone were followed. Partial remission was achieved. Half-year' follow-up showed no sign of spontaneous hemorrhage. ② Case 2, a 48-year-old female, diagnosed as monoclonal gammopathy of undetermined significance and AVWS, was presented with repeated epitaxis. The VWF: Ag level was 7%. Because the bleeding was slight and self-relieved, no specific treatment was addressed. She was followed up for one and a half year. Case 3, a 50-year-old man, diagnosed as monoclonal gammopathy of undetermined significance and AVWS, was referred to our hospital for presentation with significant hematomas. VWF: Ag was reduced to 12%. VWF-containing cryoprecipitate, plasma, intravenous immunoglobulin and rituximab were used to control his bleeding symptom. During the follow-up, spontaneous hemorrhage still occurred occasionally. Conclusions Acquired von Willebrand syndrome presented with heterogeneous symptoms. The level of VWF : Ag and VWF : Rco for patients with bleeding disorder should be performed. Abnormal bleeding symptoms in elderly patients without personal or family history of bleeding should prompt consideration of the underlying disorders. Treatment included controlling acute bleeding, curing the underlying diseases and preventing bleeding in high-risk situations. The prognosis of acquired von Willebrand syndrome is mainly related to the underlying diseases.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2016年第8期692-695,共4页 Chinese Journal of Hematology
关键词 血管性血友病 获得性 WALDENSTROM巨球蛋白血症 意义未明单克隆丙种球蛋白病 von Willebrand diseases, acquired Waldenstrom macroglobulinemia Monoclonal gammopathy of undetermined significance
  • 相关文献

参考文献14

  • 1Simone JV,Comet JA,Abildgaard CF.Acquired von Wille- brand's syndrome in systemic lupus erythematosus[J].Blood,1968,31(6):806-812. 被引量:1
  • 2Federici AB,Rand JH,Bucciarelli P,et al.Acquired von Willebrand syndrome:data from an international registry[J].Thromb Haemost,2000,84(2):345-349. 被引量:1
  • 3Federici AB,Budde U,Castaman G,et al.Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome:a 2013 update[J].Semin Thromb Hemost,2013,39(2):191-201. 被引量:1
  • 4Tsai HM,Sussman II,Nagel RL.Shear stress enhances the proteolysis of von Willebrand factor in normal plasma[J].Blood,1994,83(8):2171-2179. 被引量:1
  • 5Geisen U,Heilmann C,Beyersdorf F,et al.Non-surgical bleed- ing in patients with ventricular assist devices could be explained by acquired von Willebrand disease[J].Eur J Cardiothorac Surgs 2008,33(4):679-684. 被引量:1
  • 6Meyer AL,Malehsa D,Bara C,et al.Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device[J].Circ Heart Fail,2010,3(6):675-681. 被引量:1
  • 7Tefferi A,Nichols WL.Acquired von Willebrand disease:concise review of occurrence,diagnosis,pathogenesis,and treatment[J].Am J Med,1997,103(6):536-540. 被引量:1
  • 8毕作木.恶性血液病所致获得性血管性血友病[J].中华血液学杂志,2002,23(3):167-168. 被引量:5
  • 9Tiede A,Rand JH,Budde U,et al.How I treat the acquired von Willebrand syndrome[J].Blood,2011,117(25):6777-6785. 被引量:1
  • 10Dimopoulos MA,Anagnostopoulos A.Treatment of Walden- strom's Macroglobulinemia[J].Curr Treat Options Oncol,2007,8(2):144-153. 被引量:1

共引文献4

同被引文献20

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部